
Board Meeting28 Oct 2026, 05:11 pm
Sudeep Pharma Ltd Board Approves Unaudited Financial Results
AI Summary
Sudeep Pharma Limited announced that its Board of Directors, in a meeting held on October 28, 2026, has approved the Unaudited Standalone & Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The board meeting commenced at 03:10 p.m. and concluded at 04:25 p.m. The limited review report from B S R and Co Chartered Accountants was also submitted, confirming no material misstatements were found, although one subsidiary's financial results were not reviewed.
Key Highlights
- Board approved unaudited standalone and consolidated financial results.
- Results are for the quarter and half-year ended September 30, 2026.
- Board meeting held on October 28, 2026.
- Limited review report submitted by auditors.
- One subsidiary's results were not reviewed.
Price Impact
More from SUDEEPPHRM